Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With Advanced Chronic Kidney Disease

Stopped We screened over 200 patients but were ultimately unable to enroll anyone

Conditions

• Heart Failure, Systolic
• Renal Disease, End Stage
• Chronic Kidney Diseases

Interventions

• DRUG: Anakinra

Sponsor

Virginia Commonwealth University